Endoscopy Assessment of the Pouch in IBDYear: 2020
Source: Skills Video
Authors: Marietta Iacucci, Bo Shen
Created: Monday, 27 July 2020, 11:46 AM by Dauren Ramankulov
Last Modified: Wednesday, 2 June 2021, 4:52 PM by ECCO Administrator
Endoscopy Characterisation of Dysplastic Lesions in IBDYear: 2019
Source: Skills Videos
Authors: Marietta Iaccuci
Created: Friday, 22 February 2019, 2:56 PM by ECCO Administrator
Last Modified: Wednesday, 2 June 2021, 3:33 PM by ECCO Administrator
Endoscopy Characterisation of Dysplastic Lesions in IBD
Endoscopy or ultrasound for disease activity assessment? (Tandem Talk)Year: 2021
Source: ECCO'21 Virtual
Authors: Marietta Iacucci; Mariangela Allocca
Created: Friday, 1 October 2021, 12:41 PM
Summary contentInflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive, disabling condition. Since strategies targeting the control of symptoms do not significantly change the natural course of the diseases, mucosal healing has become the therapeutic goal to prevent disease recurrence and structural damage. However, frequent colonoscopies (CS) are expensive, invasive, and not well tolerated by patients, thus non-invasive tools for assessment and monitoring are strongly needed.
Bowel ultrasound (US) is a well-tolerated, non-invasive, patient friendly, cheap, easy-to-use tool to manage IBD patients in clinical practice. In addition, its ability to be performed as point-of-care bowel US may drastically change frequency of the assessment of treatment response, speeding the clinical decision-making process
This presentation aims to review the evidence for the use of bowel US, alternatively to CS, for the assessment and monitoring of disease activity in IBD.
Entero MRI - what to look forYear: 2021
Source: 3rd ECCO Basic Imaging Workshop in collaboration with ESGAR: Ultrasound and MRI
Authors: Pasquale Paolantonio
Created: Friday, 1 October 2021, 12:41 PM
Summary contentTechnical features of Entero-MRI (E-MRI) will be briefly illustrated from basic to advanced sequences.
Imaging findings of ileal Crohn’s disease will be reviewed in this talk with emphasis on their clinical meaning according to literature and Ecco/Esgar statements.
After this talk participants of the workshop will be able to approach in a critical manner E-MRI studies and MRI structured reports giving a guide to appreciate those findings more relevant in clinical practice in patient management.
Emphasis will be given in the definition of relevant findings such as strictures, penetrating lesions, edema and fibrosis of bowel wall.
Criteria to assess inflammation activity as well as MR scores of activity will be illustrated.
Strength and weak points of E-MRI will be discussed
Entero-MRIYear: 2019
Source: 1st ECCO-ESGAR Basic Imaging Workshop
Authors: Jordi Rimola
Created: Tuesday, 28 May 2019, 3:32 PM
Files: 1
Enterocutaneous fistulaYear: 2021
Source: 10th S-ECCO IBD Masterclass
Authors: Pär Myrelid
Created: Friday, 1 October 2021, 12:41 PM
Summary contentEducational objectives:
- To understand the risk management prior to surgery and how to prevent enterocutaneous fistulas
- To briefly understand the pre- and peroperative management of enterocutaneous fistulas
Eosinophilic enteritisYear: 2017
Source: ECCO'17 Barcelona
Authors: Annese V., Siegmund B., Feakins R., Lindsay J.
Last Modified: Wednesday, 15 March 2017, 2:23 PM by Vesna Babaja
Files: 1
Epidemiology: What links diet to IBDYear: 2022
Source: 7th D-ECCO Workshop
Authors: James Lindsay
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content1) over view of aetiology of IBD
2) discussion of diet as a precipitant: epidemiology, animal models and human studies
3) review evidence that dietary modification may impact IBD onset and natural history
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases Year: 2015
Source: JCC: Volume 9, Issue 3, 2015
Authors: Axel U. Dignass, Christoph Gasche, Dominik Bettenworth, Gunnar Birgegård, Silvio Danese, Javier P Gisbert, Fernando Gomollon, Tariq Iqbal, Konstantinos Katsanos, Ioannis Koutroubakis, Fernando Magro, Guillaume Savoye, Jürgen Stein, Stephan Vavricka
Created: Friday, 31 August 2018, 9:55 AM by Dauren Ramankulov
Last Modified: Friday, 22 February 2019, 11:25 AM by ECCO Administrator
Introduction:
Anaemia is the most common systemic complication and extraintestinal manifestation of inflammatory bowel disease [IBD].1–3 In the majority of cases, IBD-associated anaemia is a unique example of the combination of chronic iron deficiency and anaemia of chronic disease [ACD].4,5 Other more rare causes of anaemia in IBD include vitamin B12 and folate deficiency, toxic effects of medications, and others. The impact of anaemia on the quality of life of IBD patients is substantial. It affects various aspects of quality of life such as physical, emotional, and cognitive functions, the ability to work, hospitalization, and healthcare costs.6 Anaemia in IBD is not just a laboratory marker; it is a complication of IBD that needs appropriate diagnostic and therapeutic approaches.
European consensus on the histopathology of inflammatory bowel diseaseYear: 2013
Source: JCC: Volume 7, Issue 10, 2013
Authors: F. Magroa, C. Langner, A. Driessenc, A. Ensari d, K. Geboes, G.J. Mantzaris, V. Villanacci, G. Becheanuh, P. Borralho Nunes, G. Cathomas, W. Fries, A. Jouret-Mourinl, C. Mescoli, G. de Petris, C.A. Rubio, N.A. Shepherd, M. Vieth, R. Eliakim: on behalf of the European Society of Pathology (ESP) and the European Crohn's and Colitis Organisation (ECCO)
Created: Thursday, 30 August 2018, 10:51 AM by Dauren Ramankulov
Last Modified: Friday, 22 February 2019, 11:17 AM by ECCO Administrator
The histologic examination of endoscopic biopsies or resection specimens remains a key step in the work-up of affected inflammatory bowel disease (IBD) patients and can be used for diagnosis and differential diagnosis, particularly in the differentiation of UC from CD and other non-IBD related colitides. The introduction of new treatment strategies in inflammatory bowel disease (IBD) interfering with the patients' immune system may result in mucosal healing, making the pathologists aware of the impact of treatment upon diagnostic features. The European Crohn's and Colitis Organisation (ECCO) and the European Society of Pathology (ESP) jointly elaborated a consensus to establish standards for histopathology diagnosis in IBD. The consensus endeavors to address: (i) procedures required for a proper diagnosis, (ii) features which can be used for the analysis of endoscopic biopsies, (iii) features which can be used for the analysis of surgical samples, (iv) criteria for diagnosis and differential diagnosis, and (v) special situations including those inherent to therapy. Questions that were addressed include: how many features should be present for a firm diagnosis? What is the role of histology in patient management, including search for dysplasia? Which features if any, can be used for assessment of disease activity? The statements and general recommendations of this consensus are based on the highest level of evidence available, but significant gaps remain in certain areas.
European Crohn’s and Colitis Organisation Topical Review on Environmental Factors in IBDYear: 2017
Source: JCC: Volume 11, Issue 8, 2017
Authors: Christian Maaser, Ebbe Langholz, Hannah Gordon, Johan Burisch, Pierre Ellul, Vicent Hernández Ramirez, Tarkan Karakan, Konstantinos H. Katsanos, Eduards Krustins, Arie Levine, Gerassimos J. Mantzaris, Colm O’Morain, Hans Strid, Elif Saritas Yuksel, Vito Annese
Created: Friday, 31 August 2018, 11:46 AM by Dauren Ramankulov
Last Modified: Friday, 22 February 2019, 10:38 AM by ECCO Administrator
This ECCO Topical Review of the European Crohn’s and Colitis Organisation [ECCO] focuses on the role of environmental factors with respect to the development of inflammatory bowel disease [IBD] as well as their influence on the course of established IBD. The objective was to reach expert consensus to provide evidence-based guidance for clinical practice.
European Crohn’s and Colitis Organisation Topical Review on IBD in the ElderlyYear: 2017
Source: JCC: Volume 11, Issue 3, 2017
Authors: Andreas Sturm, Christian Maaser, Michael Mendall, Dimitrios Karagiannis, Pantelis Karatzas, Nienke Ipenburg, Shaji Sebastian, Fernando Rizzello, Jimmy Limdi, Konstantinos Katsanos, Carsten Schmidt, Steven Jeuring, Francesco Colombo, Paolo Gionchetti
Created: Friday, 31 August 2018, 11:35 AM by Dauren Ramankulov
Last Modified: Friday, 22 February 2019, 10:39 AM by ECCO Administrator
This ECCO topical review of the European Crohn’s and Colitis Organisation [ECCO] focuses on the epidemiology, pathophysiology, diagnosis, management and outcome of the two most common forms of inflammatory bowel disease, Crohn’s disease and ulcerative colitis, in elderly patients. The objective was to reach expert consensus to provide evidence-based guidance for clinical practice.